New anti-malarial agent with potential repository effect.
D000284:Administration, Oral; D000818:Animals; D000962:Antimalarials / Q000008:administration & dosage / Q000627:therapeutic use*; D005021:Ethylamines / Q000008:administration & dosage / Q000627:therapeutic use; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D051379:Mice; D009284:Naphthols / Q000008:administration & dosage / Q000627:therapeutic use; D010962:Plasmodium berghei; D011804:Quinolines / Q000008:administration & dosage / Q000627:therapeutic use*
D000962:Antimalarials; D005021:Ethylamines; D009284:Naphthols; D011804:Quinolines